Open AccessPCSK9 Antibody Alirocumab Attenuates Arterial Wall Inflammation Without Changes in Circulating Inflammatory Markers
Author(s) -
Renate M. Hoogeveen,
Tjerk S.J. Opstal,
Yannick Kaiser,
Lotte C.A. Stiekema,
Jeffrey Kroon,
Remco J.J. Knol,
Willem A. Bax,
Hein J. Verberne,
Jan H. Cornel,
Erik S.G. Stroes
Publication year - 2019
Publication title -
jacc. cardiovascular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.79
H-Index - 120
eISSN - 1936-878X
pISSN - 1876-7591
DOI - 10.1016/j.jcmg.2019.06.022
Subject(s) - alirocumab , pcsk9 , inflammation , medicine , arterial wall , antibody , immunology , lipoprotein , cholesterol , ldl receptor , apolipoprotein a1
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom